ACOG Committee Opinion No. 754 Summary: The Utility of and Indications for Routine Pelvic Examination.

  title={ACOG Committee Opinion No. 754 Summary: The Utility of and Indications for Routine Pelvic Examination.},
  author={Lubna Chohan},
  journal={Obstetrics and gynecology},
  volume={132 4},
  • L. Chohan
  • Published 1 October 2018
  • Medicine
  • Obstetrics and gynecology
The pelvic examination has long been considered a fundamental component of the well-woman visit, and many women and gynecologic care providers view this visit as an opportunity to discuss sexual and reproductive health issues. Traditionally, a pelvic examination is performed for asymptomatic women as a screening tool for gynecologic cancer, infection, and asymptomatic pelvic inflammatory disease; some obstetrician-gynecologists and patients consider it important in detecting subclinical disease… 
7 Citations

Patterns of cervical cancer screening among Medicaid beneficiaries

The use of cervical cancer screening among average‐risk Medicaid beneficiaries is examined and cytological screening with or without cytology is recommended for women age 30–65 years.

Opposition to Pharmacist Contraception Services: Evidence for Rebuttal

This article can serve as a guide for pharmacists and advocates when discussing pharmacist-prescribed contraception with policymakers, patients, and other healthcare professionals.

The Well-Woman Visit

A well-woman visit provides an excellent opportunity to counsel patients about maintaining a healthy lifestyle and minimizing health risks. Given the shifting and complex landscape of care, in which



Do new guidelines and technology make the routine pelvic examination obsolete?

Eliminating the speculum examination from most visits and the bimanual examination from all visits of asymptomatic women will free resources to provide services of proven benefit, as overuse contributes to high healthcare costs without any compensatory health benefit.

Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women.

Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians

This systematic review evaluated the benefits and harms of routine screening pelvic examination in asymptomatic, nonpregnant adult women for indications other than sexually transmitted infection screening before provision of hormonal contraception and cervical cancer screening and did not address pelvic examinations for symptomatic women or women at higher-than-average risk for gynecologic cancer.

Effect of professional society recommendations on women’s desire for a routine pelvic examination

Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians.

This guideline grades the evidence and recommendations using the ACP's clinical practice guidelines grading system and recommends against performing screening pelvic examination in asymptomatic, nonpregnant, adult women.

Women's beliefs about the purpose and value of routine pelvic examinations

Periodic Screening Pelvic Examination: Evidence Report and Systematic Review for the US Preventive Services Task Force

No direct evidence was identified for overall benefits and harms of the pelvic examination as a 1-time or periodic screening test for asymptomatic primary care populations.

Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.

New recommendations for the periodic well-woman visit: impact on counseling.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

The group's goal was to provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screenings tests, cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS) following adoption of cervical cancer screening guidelines incorporating longer screening intervals and co-testing.